INI SS July 2024- Dates Revised For Stage II Departmental Assessment for 2 DM Courses

Published On 2024-05-12 08:00 GMT   |   Update On 2024-05-12 08:01 GMT

New Delhi- Through a notice, All India Institute of Medical Sciences (AIIMS) has informed about the revised date of For Stage II Departmental Assessment for 2 DM Courses i.e. Pediatric Haematology Oncology and Reproductive Medicine f

Recently, AIIMS has declared the result of Stage- I of the Institute of National Importance Super-Specialty Entrance Examination (INI-SS) for admission to DM, M.Ch and MD (Hospital Administration) courses at AIIMS and PGIMER Chandigarh for the July 2024 session.

In the result, the dates of Stage II (Departmental Assessment) were indicated against each course. Therefore, as per the result, both the Pediatric Haematology Oncology and Reproductive Medicine were decided to be held on 16 May 2024. Now, the dates have been revised in both of these courses where Pediatric Hematology Oncology will be on 15th May 2024 and Reproductive Medicine on 17th May 2024. However, the rest of the dates remain unchanged.

Advertisement

Talking about the result, a total of 800 candidates had qualified in DM and MCh, however, no candidates were qualified in MD (Hospital Administration) courses for Stage II. Of these, 39 candidates were from the sponsored category and 8 candidates were foreign nationals. Meanwhile, no candidate applied for 5 DM courses i.e. High Altitude Medicine, Pediatric Cardiology, Pediatric Pulmonology & Intensive Care, Pain Medicine and Virology.

However, today, till 12:00 noon was the last date to upload the scanned copies for the qualified candidates for Stage- II.

The written examination through online (CBT) mode for INI SS was held on Saturday, 27th April 2024 in 16 cities of India like Ahmedabad, Puducherry, Bhopal, Bhopal. The course is scheduled to resume from 01 July 2024. INI-SS entrance exam was related to admission to DM, M.Ch and MD (Hospital Administration) courses for AIIMS, PGIMER, NIMHANS, SCTIMST and JIPMER for July 2024 session.

To view the notice, click the link below

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News